MRRSE has added a new research report on the "Transcatheter Embolization and Occlusion Devices Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024" to its collection.
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Transcatheter embolization and occlusion devices market analysis detailed profiles of top industry players and their segments till 2024
1. Transcatheter Embolization and Occlusion Devices Market
Analysis Detailed Profiles of Top Industry Players and Their
Segments Till 2024
Report Description
Transcatheter Embolization and Occlusion Devices Market:
Snapshot
2. The transcatheter embolization and occlusion (TEO) devices
market has witnessed strong growth in the past few years
due to the rising focus on innovation, resulting in higher
product approvals and product launches globally. The market
is also characterized by significant research and development
leading to several technological innovations.
Request a Sample Copy of the Report @
http://www.mrrse.com/sample/2148
In terms of revenue, the global TEO devices market was
valued at US$2.4 bn in 2015 and is projected to reach
US$4.8 bn by 2024 at a CAGR of 7.9% therein. In terms of
3. volume, the global market is anticipated to register a CAGR
of 8.1% from 2016 to 2024.
High Prevalence of Obesity Drives Use of TEO Devices in
Treating Peripheral Vascular Diseases
Embolization coils are the leading products in the market, as
these are one of the oldest embolization products available in
the market. However, the embolization particles and flow
diverter devices segments are expected to record a high
CAGR during the forecast period.
Inquiry on this report @ http://www.mrrse.com/enquiry/2148
4. Based on application, the peripheral vascular disease segment
dominates the transcatheter embolization and occlusion
devices market. This segment is expected to continue its lead
through 2024 due to a growing geriatric population, changing
lifestyles leading to a high prevalence of obesity, and the
rising demand for minimally-invasive procedures. However,
the oncology segment is expected to record a high CAGR
during the forecast period due to the rising prevalence of
cancer across the globe.
By end use, the hospitals segment captured a considerable
market share and is likely to remain a key segment in the
5. transcatheter embolization and occlusion devices market,
expanding at a high CAGR during the forecast period.
Booming Medical Tourism Industry Contributing toward
Growth of APAC TEO Devices Market
North America accounted for a major share in the global
transcatheter embolization and occlusion devices market in
2015 due to the presence of leading market players in the
region. Most of these companies operating in the region have
made a series of strategic acquisitions, which contributes to
an increase in their market share. The growing prevalence of
cancer in the region is one of the primary factors
contributing to the growth of the transcatheter embolization
6. and occlusion devices market. According to the American
Cancer Society, over 1,658,370 new cancer cases were
diagnosed and 589,430 cancer deaths reported in the U.S. in
2015 alone. Well-established reimbursement policies by
private or public organizations for TEO devices is also a
major factor spurring the adoption of these devices North
America.
Read Complete Report with TOC @
http://www.mrrse.com/transcatheter-embolization-occlusion-
devices-market
The transcatheter embolization and occlusion devices market
in Asia Pacific is expected to expand at a high CAGR during
7. the forecast period. A large patient pool and rising awareness
about transcatheter embolization procedures are the key
factors driving the adoption of TEO devices in the region.
The booming medical tourism industry, driven by rising
government support and the incorporation of different
schemes by the government to avail better treatment for
patients, is also expected to propel the transcatheter
embolization and occlusion devices market. An increase in
the number of localized manufacturers and the strengthening
of the distribution network in Asia Pacific due to a rapidly
growing economy offer significant benefits for market players
as far as investments are concerned. A surge in the
prevalence of neurovascular diseases and cancer in several
8. countries across Asia Pacific is projected to fuel the market
in the coming years.
About MRRSE
MRRSE stands for Market Research Reports Search Engine,
the largest online catalog of latest market research reports
based on industries, companies, and countries. MRRSE
sources thousands of industry reports, market statistics, and
company profiles from trusted entities and makes them
available at a click. Besides well-known private publishers,
the reports featured on MRRSE typically come from national
statistics agencies, investment agencies, leading media houses,
trade unions, governments, and embassies.
9. Contact US:
Corporate Office
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-730-0559
Email: sales@mrrse.com